Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2017 Earnings

7NovConfirmed

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-0.73

-0.66

-0.6

-0.53

Details

Expected EPS

-0.62

Actual EPS

-0.53

Surprise EPS

0.09

Surprise Percent

+14.52%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.53 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.